Trial Profile
Effectiveness of apixaban In patients with non-valvular atrial fibrillation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2015
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Embolism; Stroke
- Focus Adverse reactions; Therapeutic Use
- 09 Oct 2015 New trial record
- 06 Oct 2015 Results published in the Circulation Journal.